Skip to main content
. 2020 Oct;9(5):1853–1861. doi: 10.21037/tlcr-20-382

Figure 2.

Figure 2

Distribution of EGFR ex20ins mutants in 73 NSCLC patients (I–IIIA) according to different classes by functional classification [(A) left side)] and 119 advanced NSCLC patients (IIIB–IV) according to different classes by functional classification [(A) right side)]. Number of ex20ins mutants (B). EGFR ex20ins, epidermal growth factor receptor exon 20 insertion; NSCLC, non-small-cell lung cancer.